
Laura Lynne Stockton
Examiner (ID: 15659, Phone: (571)272-0710 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1201, 2899, 1626, 1613, 1614, 1646 |
| Total Applications | 3283 |
| Issued Applications | 2225 |
| Pending Applications | 331 |
| Abandoned Applications | 760 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7784747
[patent_doc_number] => 20120046303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-23
[patent_title] => 'BENZIMIDAZOLE POLY(ADP RIBOSE)POLYMERASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/282826
[patent_app_country] => US
[patent_app_date] => 2011-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24347
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20120046303.pdf
[firstpage_image] =>[orig_patent_app_number] => 13282826
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/282826 | BENZIMIDAZOLE POLY(ADP RIBOSE)POLYMERASE INHIBITORS | Oct 26, 2011 | Abandoned |
Array
(
[id] => 9704135
[patent_doc_number] => 08829200
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-09
[patent_title] => 'Benzimidazole inhibitors of leukotriene production'
[patent_app_type] => utility
[patent_app_number] => 13/281685
[patent_app_country] => US
[patent_app_date] => 2011-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13990
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13281685
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/281685 | Benzimidazole inhibitors of leukotriene production | Oct 25, 2011 | Issued |
Array
(
[id] => 8896930
[patent_doc_number] => 08476452
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-02
[patent_title] => 'Process for preparing 1,2-benzoisothiazoline-3-one'
[patent_app_type] => utility
[patent_app_number] => 13/281600
[patent_app_country] => US
[patent_app_date] => 2011-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1754
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13281600
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/281600 | Process for preparing 1,2-benzoisothiazoline-3-one | Oct 25, 2011 | Issued |
Array
(
[id] => 7778659
[patent_doc_number] => 20120041041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => '5-HYDROXY-BENZOTHIAZOLE DERIVATIVES HAVING BETA-2-ADRENORECEPTOR AGONIST ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/278636
[patent_app_country] => US
[patent_app_date] => 2011-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8313
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20120041041.pdf
[firstpage_image] =>[orig_patent_app_number] => 13278636
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/278636 | 5-HYDROXY-BENZOTHIAZOLE DERIVATIVES HAVING BETA-2-ADRENORECEPTOR AGONIST ACTIVITY | Oct 20, 2011 | Abandoned |
Array
(
[id] => 8199558
[patent_doc_number] => 20120122943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'Melampomagnolide B Derivatives as Antileukemic and Cytotoxic Agents'
[patent_app_type] => utility
[patent_app_number] => 13/279038
[patent_app_country] => US
[patent_app_date] => 2011-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 21084
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20120122943.pdf
[firstpage_image] =>[orig_patent_app_number] => 13279038
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/279038 | Melampomagnolide B derivatives as antileukemic and cytotoxic agents | Oct 20, 2011 | Issued |
Array
(
[id] => 8936671
[patent_doc_number] => 20130186468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'PHOTOELECTRIC CONVERSION DEVICE AND PHOTOELECTRIC CONVERSION DEVICE DYE, AND COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 13/876618
[patent_app_country] => US
[patent_app_date] => 2011-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22914
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876618
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/876618 | Photoelectric conversion device and photoelectric conversion device dye, and compound | Sep 26, 2011 | Issued |
Array
(
[id] => 10920720
[patent_doc_number] => 20140323741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'DYES FOR LABELLING MOLECULAR LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 14/346657
[patent_app_country] => US
[patent_app_date] => 2011-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11368
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14346657
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/346657 | Dyes for labelling molecular ligands | Sep 22, 2011 | Issued |
Array
(
[id] => 7733403
[patent_doc_number] => 20120015911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'METHOD AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/237576
[patent_app_country] => US
[patent_app_date] => 2011-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 123298
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015911.pdf
[firstpage_image] =>[orig_patent_app_number] => 13237576
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/237576 | Method and compositions for treating amyloid-related diseases | Sep 19, 2011 | Issued |
Array
(
[id] => 9127410
[patent_doc_number] => 08575361
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-05
[patent_title] => 'Tetrahydronaphthalene derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/227047
[patent_app_country] => US
[patent_app_date] => 2011-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18707
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13227047
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/227047 | Tetrahydronaphthalene derivatives | Sep 6, 2011 | Issued |
Array
(
[id] => 7808032
[patent_doc_number] => 20120058986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'DI-AZETIDINYL DIAMIDE AS MONOACYLGLYCEROL LIPASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/224654
[patent_app_country] => US
[patent_app_date] => 2011-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24519
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058986.pdf
[firstpage_image] =>[orig_patent_app_number] => 13224654
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/224654 | DI-AZETIDINYL DIAMIDE AS MONOACYLGLYCEROL LIPASE INHIBITORS | Sep 1, 2011 | Abandoned |
Array
(
[id] => 8990607
[patent_doc_number] => 20130217888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'PROCESS FOR PREPARING BENDAMUS TINE HYDROCHLORIDE MONOHYDRATE'
[patent_app_type] => utility
[patent_app_number] => 13/635097
[patent_app_country] => US
[patent_app_date] => 2011-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8287
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13635097
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/635097 | PROCESS FOR PREPARING BENDAMUS TINE HYDROCHLORIDE MONOHYDRATE | Aug 28, 2011 | Abandoned |
Array
(
[id] => 9552487
[patent_doc_number] => 08759537
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-24
[patent_title] => '3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents'
[patent_app_type] => utility
[patent_app_number] => 13/211470
[patent_app_country] => US
[patent_app_date] => 2011-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25794
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13211470
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/211470 | 3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents | Aug 16, 2011 | Issued |
Array
(
[id] => 7784773
[patent_doc_number] => 20120046329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-23
[patent_title] => 'MODULATORS OF NOD1 AND NOD2 SIGNALING, METHODS OF IDENTIFYING MODULATORS OF NOD1 AND NOD2 SIGNALING, AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/207325
[patent_app_country] => US
[patent_app_date] => 2011-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 48257
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20120046329.pdf
[firstpage_image] =>[orig_patent_app_number] => 13207325
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/207325 | MODULATORS OF NOD1 AND NOD2 SIGNALING, METHODS OF IDENTIFYING MODULATORS OF NOD1 AND NOD2 SIGNALING, AND USES THEREOF | Aug 9, 2011 | Abandoned |
Array
(
[id] => 8541173
[patent_doc_number] => RE043833
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2012-11-27
[patent_title] => 'Thiazolidin-4-one derivatives'
[patent_app_type] => reissue
[patent_app_number] => 13/205768
[patent_app_country] => US
[patent_app_date] => 2011-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19222
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13205768
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/205768 | Thiazolidin-4-one derivatives | Aug 8, 2011 | Issued |
Array
(
[id] => 8854205
[patent_doc_number] => 20130143880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'POSITIVE ALLOSTERIC MODULATORS OF MGLUR2'
[patent_app_type] => utility
[patent_app_number] => 13/814870
[patent_app_country] => US
[patent_app_date] => 2011-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26205
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13814870
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/814870 | Positive allosteric modulators of MGLUR2 | Aug 4, 2011 | Issued |
Array
(
[id] => 9016413
[patent_doc_number] => 20130231377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'PACTAMYCIN ANALOGS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/813144
[patent_app_country] => US
[patent_app_date] => 2011-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 23619
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813144
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/813144 | PACTAMYCIN ANALOGS AND METHODS OF USE | Aug 1, 2011 | Abandoned |
Array
(
[id] => 8854390
[patent_doc_number] => 20130144065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'SEMICONDUCTOR MATERIALS PREPARED FROM BRIDGED BITHIAZOLE COPOLYMERS'
[patent_app_type] => utility
[patent_app_number] => 13/810819
[patent_app_country] => US
[patent_app_date] => 2011-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28935
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810819
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/810819 | SEMICONDUCTOR MATERIALS PREPARED FROM BRIDGED BITHIAZOLE COPOLYMERS | Jul 28, 2011 | Abandoned |
Array
(
[id] => 7757086
[patent_doc_number] => 20120029029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'SUBSTITUTED THIAZOL-2-YLAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS 11-BETA HSD1 MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/189640
[patent_app_country] => US
[patent_app_date] => 2011-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14070
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20120029029.pdf
[firstpage_image] =>[orig_patent_app_number] => 13189640
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/189640 | Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta HSD1 modulators | Jul 24, 2011 | Issued |
Array
(
[id] => 8896931
[patent_doc_number] => 08476453
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-02
[patent_title] => 'Process for the preparation of dimiracetam'
[patent_app_type] => utility
[patent_app_number] => 13/811727
[patent_app_country] => US
[patent_app_date] => 2011-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2531
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811727
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/811727 | Process for the preparation of dimiracetam | Jul 24, 2011 | Issued |
Array
(
[id] => 9055258
[patent_doc_number] => 20130252972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'ISOXAZOLE, ISOTHIAZOLE, FURANE AND THIOPHENE COMPOUNDS AS MICROBICIDES'
[patent_app_type] => utility
[patent_app_number] => 13/810976
[patent_app_country] => US
[patent_app_date] => 2011-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21208
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810976
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/810976 | ISOXAZOLE, ISOTHIAZOLE, FURANE AND THIOPHENE COMPOUNDS AS MICROBICIDES | Jul 18, 2011 | Abandoned |